Matza LS - Search Results

1

Development and validation of a patient-report measure of fatigue associated with depression.

Matza LS, Phillips GA, Revicki DA, Murray L, Malley KG. Matza LS, et al. J Affect Disord. 2011 Nov;134(1-3):294-303. doi: 10.1016/j.jad.2011.06.028. Epub 2011 Aug 5. J Affect Disord. 2011. PMID: 21820183

2

Health state utilities associated with hyperphagia: Data for use in cost-utility models.

Howell TA, Matza LS, Mallya UG, Goldstone AP, Butsch WS, Lazarus E. Howell TA, et al. Among authors: matza ls. Obes Sci Pract. 2023 Feb 1;9(4):376-382. doi: 10.1002/osp4.652. eCollection 2023 Aug. Obes Sci Pract. 2023. PMID: 37546284 Free PMC article.

3

Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences.

Matza LS, Revicki DA, Davidson JR, Stewart JW. Matza LS, et al. Arch Gen Psychiatry. 2003 Aug;60(8):817-26. doi: 10.1001/archpsyc.60.8.817. Arch Gen Psychiatry. 2003. PMID: 12912765

4

The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder.

Matza LS, Rentz AM, Secnik K, Swensen AR, Revicki DA, Michelson D, Spencer T, Newcorn JH, Kratochvil CJ. Matza LS, et al. J Dev Behav Pediatr. 2004 Jun;25(3):166-74. doi: 10.1097/00004703-200406000-00005. J Dev Behav Pediatr. 2004. PMID: 15194901 Clinical Trial.

5

Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials.

Revicki DA, Matza LS, Flood E, Lloyd A. Revicki DA, et al. Among authors: matza ls. Pharmacoeconomics. 2005;23(6):583-94. doi: 10.2165/00019053-200523060-00005. Pharmacoeconomics. 2005. PMID: 15960554 Review.

6

Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review.

Matza LS, Baker TM, Revicki DA. Matza LS, et al. CNS Drugs. 2005;19(6):499-515. doi: 10.2165/00023210-200519060-00003. CNS Drugs. 2005. PMID: 15963000 Review.

7

Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder.

Rentz AM, Matza LS, Secnik K, Swensen A, Revicki DA. Rentz AM, et al. Among authors: matza ls. Qual Life Res. 2005 Apr;14(3):719-34. doi: 10.1007/s11136-004-0832-9. Qual Life Res. 2005. PMID: 16022065

8

Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report.

Matza LS, Secnik K, Rentz AM, Mannix S, Sallee FR, Gilbert D, Revicki DA. Matza LS, et al. Qual Life Res. 2005 Apr;14(3):735-47. doi: 10.1007/pl00022070. Qual Life Res. 2005. PMID: 16022066

9

Depression and health-related quality of life for low-income African-American women in the U.S.

Frank LB, Matza LS, Revicki DA, Chung JY. Frank LB, et al. Among authors: matza ls. Qual Life Res. 2005 Dec;14(10):2293-301. doi: 10.1007/s11136-005-6541-1. Qual Life Res. 2005. PMID: 16328908

10

The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder.

Coyne KS, Matza LS, Kopp Z, Abrams P. Coyne KS, et al. Among authors: matza ls. Eur Urol. 2006 Jun;49(6):1079-86. doi: 10.1016/j.eururo.2006.01.007. Epub 2006 Jan 24. Eur Urol. 2006. PMID: 16460875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters